Home›Companies›Healthcare›Intellihealth

Intellihealth, Inc.

Updated Oct 27, 2026·Latest SEC filing Nov 26, 2025·Suggest an edit

About Intellihealth

Intellihealth is a private company based in New Canaan, Connecticut. It has reported $31,315,338 raised in three offerings on Form D since July 2021. Its chief executive is Cheryl Pegus.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 12, 2025Nov 26, 2025$5,239,998of $9.9M target11$476KEquityRule 506(b)Form D ↗
Aug 9, 2023Aug 22, 2023amended Mar 25, 2024$15,399,999of $17.0M target30$513KEquityRule 506(b)Form D/A ↗1 earlier filing
Jun 25, 2021Jul 19, 2021$10,675,341fully sold45$237KEquityRule 506(b)Form D ↗
Total, three offerings$31,315,338

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Intellihealth's Form D filed Nov 26, 2025.

JD
Jason Dinges
Director
LA
Louis Aronne
Director
SS
Sloan Saunders
Executive officer, director and promoter
SR
SE
CP
Cheryl Pegus
Chief Executive Officer and director

Earlier filings also listed Shelly Lanning (director, last listed Jul 2021) and David Bass (executive officer, last listed Jul 2021).

Sources

  1. SECIntellihealth, Inc. Form D, filed Aug 22, 2023
  2. SECIntellihealth, Inc. filing history